Guangji Pharmaceutical (Mengzhou) Co. Ltd. announced that it will received CNY 180,000,000 in an equity round of funding on August 5, 2021. The transaction will include particpation from returning investor Hubei Guangji Pharmaceutical Co., Ltd. The transaction has been approved at the 5th Extraordinary Meeting of the 10th Directorate and the 5th Extraordinary Meeting of the 10th Supervisory Board of the investor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.36 CNY | -2.01% |
|
+6.14% | -32.92% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.92% | 26Cr | |
+54.07% | 81TCr | |
+38.95% | 62TCr | |
-7.05% | 35TCr | |
+15.44% | 32TCr | |
+5.72% | 29TCr | |
+14.31% | 24TCr | |
-0.53% | 22TCr | |
+14.61% | 22TCr | |
+7.42% | 17TCr |
- Stock Market
- Equities
- 000952 Stock
- News Hubei Guangji Pharmaceutical Co., Ltd.
- Guangji Pharmaceutical Co. Ltd. announced that it expects to receive CNY 180 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.